vimarsana.com
Home
Live Updates
Real-World Evidence Shows 82% Reduction in Infant RSV Hospit
Real-World Evidence Shows 82% Reduction in Infant RSV Hospit
Real-World Evidence Shows 82% Reduction in Infant RSV Hospitalizations With Nirsevimab
The results reinforce other real-world evidence from several broad infant immunization programs in the US, Spain, and France.
Related Keywords
Spain ,
France ,
Federico Martinon Torres ,
Astrazeneca ,
Advisory Committee On Immunization Practices ,
Vaccine Surveillance Network ,
Sukjai Photo ,
Universitario Santiago ,
Immunization Practices ,
Routine Use ,
Protect Infants ,
Young Children Against Respiratory Syncytial ,
Address Shortage ,